ReachMD

Episodes 1-15 of 29

• • 

    

    Kristen Whitaker, MD, MS

    Peer

  • 

    

    Ricki Fairley, BA, MBA

    Peer

  • 

    

    Sara M. Tolaney, MD, MPH

    Peer

  0

  

  RestartResume

  Advances in the Standard of Care in TNBC: Addressing Health Disparities and Integrating ADCs Into Treatment

  Advances in the Standard of Care in TNBC: Addressing Health Disparities and Integrating ADCs Into Treatment

  1.00 credits

• • 

    

    Miguel A. Escobar, MD

    Peer

  • 

    

    Cindy Leissinger, MD

    Peer

  • 

    

    Guy Young, MD

    Peer

  0

  

  RestartResume

  Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life

  Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life

  1.00 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Sandip Patel, MD

    Peer

  0

  

  RestartResume

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  0

  

  RestartResume

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Vivek Subbiah, MD

    Peer

  1

  

  RestartResume

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  0.25 credits

• • 

    

    Hyunseok “Hyu” Kang, MD, MPH

    Peer

  • 

    

    Jochen Lorch, MD

    Peer

  0

  

  RestartResume

  A New Chapter for Oral Precision Therapies in Thyroid Cancer: RET Inhibitors

  A New Chapter for Oral Precision Therapies in Thyroid Cancer: RET Inhibitors

  1.00 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  0

  

  RestartResume

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  0.25 credits

• • 

    

    Sara A. Hurvitz, MD, FACP

    Peer

  • 

    

    William J. Gradishar MD, FASCO, FACP

    Peer

  • 

    

    Nancy U. Lin, MD

    Peer

  1

  

  RestartResume

  Improving the Standard of Care in Community-Based HER2-Positive Metastatic Breast Cancer

  Improving the Standard of Care in Community-Based HER2-Positive Metastatic Breast Cancer

  0.25 credits
• 0

  

  RestartResume

  Digital Flashcards: HER2+ mBC

  Digital Flashcards: HER2+ mBC

  0.25 credits

• • 

    

    Adam M. Brufsky, MD, PhD

    Peer

  • 

    

    Nina Thomas, MD

    Peer

  2

  

  RestartResume

  Identifying and Managing Cancer Therapy-Induced Interstitial Lung Disease (ILD) and Pneumonitis

  Identifying and Managing Cancer Therapy-Induced Interstitial Lung Disease (ILD) and Pneumonitis

  1.00 credits

• • 

    

    Peter Libby, MD

    Peer

  • 

    

    Lawrence A. Leiter, MD

    Peer

  • 

    

    Prof. Kausik Ray, MBChB, MD, MPhil

    Peer

  1

  

  RestartResume

  Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction

  Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction

  0.25 credits

• • 

    

    Daniel P. Petrylak, MD

    Peer

  • 

    

    Arlene O. Siefker-Radtke, MD

    Peer

  2

  

  RestartResume

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Justin Gainor, MD

    Peer

  1

  

  RestartResume

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  0.25 credits

• • 

    

    Misako Nagasaka, MD, PhD

    Peer

  2

  

  RestartResume

  The Clinical Playbook: Team-based Integration of ADCs in Metastatic NSCLC

  The Clinical Playbook: Team-based Integration of ADCs in Metastatic NSCLC

  1.00 credits

• • 

    

    Jeffrey S. Weber, MD, PhD

    Peer

  1

  

  RestartResume

  Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma

  Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma

  1.00 credits

• 1
• 2
• Next